Concepedia
Statistics
Publications
5
Citations
161
H-Index
Active since
2006
Affiliations
Pfizer (United Kingdom)(Current)
McMaster University
Steven Kelly is an author at Pfizer (United Kingdom) specializing in medicine, ophthalmology, and macular degeneration.
Publications per year
2006–2011
Multiple treatment comparison meta-analyses: a step forward into complexity
Edward Mills, Nick Bansback, Ghement et al. · Clinical Epidemiology · 2011 · 101 citations · Full text
Public Health, Biostatistics, Comparative Effectiveness Research +14
Cost Effectiveness of Pegaptanib for the Treatment of Age-Related Macular Degeneration in the UK
Sorrel Wolowacz, Neil Roskell, Steven Kelly et al. · PharmacoEconomics · 2007 · 21 citations
Medicine, Ophthalmology, Pharmacoeconomics +7
Persistence of glaucoma medical therapy in the Glasgow Glaucoma Database
MJ Rahman, Shyharini Abeysinghe, Steven Kelly et al. · British Journal of Ophthalmology · 2011 · 14 citations · Full text
Medicine, Ophthalmology, Pharmacotherapy +13
A randomized trial of Pegaptanib sodium for age-related macular degeneration used an innovative design to explore disease-modifying effects
Edward J. Mills, Diane Heels‐Ansdell, Steven Kelly et al. · Journal of Clinical Epidemiology · 2006 · 13 citations
Medicine, Ophthalmology, Pharmacology +10
Epidemiology and reporting of randomized trials employing re-randomization of patient groups: A systematic survey
Edward J. Mills, Steven Kelly, Ping Wu et al. · Contemporary Clinical Trials · 2006 · 12 citations
Public Health, Biostatistics, Health Sciences +16
1–5 of 5